VT News

Roberto Petagine

Ask VT AI
View News Summary
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
  • Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
  • Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Roberto Petagine

Top Topics

Trending in U.S.

World

Sport